Welcome to our web page about the NHS-Galleri GRAIL trial. The East of England Cancer Alliance has been supporting the delivery of the NHS-Galleri trial in the north of the region. Galleri™ is a blood test to detect cancer, often before symptoms appear.
The NHS-Galleri trial is a research trial to see how well the new Galleri™ test works in the NHS when used alongside standard cancer screening. The aim is to see whether the test can help to find cancers at an early stage when they are easier to treat. The trial has been running for three years now with testing now complete in the East of England and across the country.
The study is in partnership with NHS England and GRAIL and is being run by The Cancer Research UK & King’s College London Cancer Prevention Trials Unit, a team of cancer researchers and trial managers at King's College London (King’s). GRAIL LLC. is a company in the United States that developed the Galleri test. They have also set up a branch in the UK, GRAIL Bio UK Ltd (GRAIL) who are the main funder and organiser of this trial. For more information, visit the NHS-Galleri website at: nhs-galleri.org
The videos below show why participants have taken part in the trial, the role of the cancer alliances, background to the trial and a longer video about NHS-Galleri.